NCT04442126 2025-05-23A Study of NM21-1480 in Adult Patients With Advanced Solid TumorsNumab Therapeutics AGPhase 1/2 Terminated52 enrolled 33 charts
NCT03621982 2024-06-13Study of ADCT-301 in Patients With Selected Advanced Solid TumorsADC Therapeutics S.A.Phase 1 Terminated78 enrolled 39 charts
NCT01010126 2019-01-25Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerNational Cancer Institute (NCI)Phase 2 Completed252 enrolled 20 charts
NCT01243762 2018-08-16A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)Merck Sharp & Dohme LLCPhase 1 Terminated47 enrolled 12 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts